Latest News

Pregabalin effectively treats restless leg syndrome with less risk of worsening symptoms, study finds

A year-long study has found that pregabalin -- which is FDA-approved to treat nerve pain, seizures, and other conditions -- was effective in reducing symptoms of restless leg syndrome and that long-term pregabalin treatment was less likely than pramipexole -- one of several drugs that activate the dopamine neurotransmission system and are FDA approved for RLS treatment -- to cause worsening of symptoms.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Fear, safety and the role of sleep in human PTSD: Fragmented REM sleep may hinder effective treatment

  • Study reveals drivers of Western consumers' readiness to eat insects

  • Computer games give a boost to English

  • How nerve cells communicate with each other over long distances: Travelling by resonance

  • Serotonin deficiency? Study throws into question long-held belief about depression

  • Marijuana compound may offer treatment for Alzheimer's disease, study suggests

  • Gang life brings deep health risks for girls

  • First study of brain activation in multiple sclerosis using fNIRS

  • Readers with dyslexia have disrupted network connections in the brain, map the circuitry of dyslexia shows

  • Avatars make the Internet sign to deaf people

  •